Faheem Hasnain

(Mr. Faheem Hasnain)

Currently holds positions in Mirati Therapeutics Inc, Gossamer Bio Inc, Tocagen Inc and Kura Oncology Inc

Positions
Position Company Period
Chairman of the Board Mirati Therapeutics Inc Feb. 15, 2019 -
Executive Chairman of the Board Gossamer Bio Inc July 1, 2018 -
Independent Chairman of the Board Tocagen Inc Oct. 1, 2014 -
Lead Independent Director Kura Oncology Inc March 1, 2020 -
Independent Director Kura Oncology Inc April 1, 2015 - March 1, 2020
Chairman of the Board Immunic Inc Sept. 6, 2017 - April 12, 2019
Director Immunic Inc Aug. 11, 2016 - Sept. 6, 2017
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-03-28 2024-03-27
S Sale
23,172 -16.2%
1.16
26,773 USD 		23,172 -16.2% 1.16 26,773 USD
2023-08-14 2023-08-11
B Purchase
10,791 +inf%
27.80
299,990 USD 		10,791 +inf% 27.80 299,990 USD
2023-03-22 2023-03-22
B Purchase
440,500 +10.9%
1.14
503,580 USD 		440,500 +10.9% 1.14 503,580 USD
2023-03-22 2023-03-21
B Purchase
269,389 +7.1%
1.20
322,324 USD 		269,389 +7.1% 1.20 322,324 USD
2023-03-22 2023-03-20
B Purchase
168,683 +4.7%
1.03
174,486 USD 		168,683 +4.7% 1.03 174,486 USD
2022-03-24 2022-03-23
S Sale
19,035 -11.7%
8.92
169,697 USD 		19,035 -11.7% 8.92 169,697 USD
2020-10-14 2020-10-14
B Purchase
96,520 +2.9%
10.36
999,995 USD 		96,520 +2.9% 10.36 999,995 USD
2019-09-27 2019-09-27
B Purchase
10,000 +0.3%
16.80
167,980 USD 		10,000 +0.3% 16.80 167,980 USD
2019-06-03 2019-05-30
US Tocagen Inc (TOCA)
B Purchase
250 +0.1%
5.15
1,287 USD 		250 +0.1% 5.15 1,287 USD
2019-06-03 2019-05-30
US Tocagen Inc (TOCA)
B Purchase
3,890 +1.6%
5.30
20,613 USD 		3,890 +1.6% 5.30 20,613 USD
2019-06-03 2019-05-30
US Tocagen Inc (TOCA)
B Purchase
38,860 +19.2%
4.59
178,414 USD 		38,860 +19.2% 4.59 178,414 USD
2018-09-17 2018-09-13
US Immunic Inc (IMUX)
S Sale
118,243 -96.3%
0.44
51,767 USD 		118,243 -96.3% 0.44 51,767 USD
2018-09-17 2018-09-13
US Immunic Inc (IMUX)
S Sale
59,200 -32.5%
0.44
25,912 USD 		59,200 -32.5% 0.44 25,912 USD
2017-09-15 2017-09-14
US Immunic Inc (IMUX)
B Purchase
59,200 +48.2%
4.19
247,870 USD 		59,200 +48.2% 4.19 247,870 USD
2017-04-21 2017-04-19
US Tocagen Inc (TOCA)
B Purchase
100,000 +97.2%
10.00
1,000,000 USD 		100,000 +97.2% 10.00 1,000,000 USD
2016-08-15 2016-08-12
US Immunic Inc (IMUX)
B Purchase
118,243 +2627.6%
5.92
699,999 USD 		118,243 +2627.6% 5.92 699,999 USD